Exited in: 2018
Thorne Research is a leader in the formulation, manufacture and distribution of hypo-allergenic, premium natural dietary supplements sold through licensed health care practitioners for use by their patients. The Company’s over 300 dietary supplements are recognized by health care practitioners around the world as being the finest, purest, highest quality dietary supplements available.
For over 30 years, Thorne Research has been dedicated to enhancing the health and well-being of people worldwide by providing innovative, high-quality, research-based nutritional supplements, health diagnostics technology platforms, and the latest in medical education.
Through our products and services, our passionate, talented staff, collaboration with a variety of innovative and expert strategic partners, and an unwavering commitment to integrity, Thorne Research strives to become a leading health-care company serving people around the world.
In October 2018, Thorne completed a recapitalization of the Company with Mitsui & Co., Ltd. (Mitsui) and Kirin Holdings Company, Limited (Kirin) which included the repurchase of WestView’s shares.